HomeComparePEAR vs CL

PEAR vs CL: Dividend Comparison 2026

PEAR yields 6849.32% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEAR wins by $1339387406433213.75M in total portfolio value
10 years
PEAR
PEAR
● Live price
6849.32%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1339387406433213.75M
Annual income
$1,301,993,616,197,644,700,000.00
Full PEAR calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — PEAR vs CL

📍 PEAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEAR + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PEAR pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEAR
Annual income on $10K today (after 15% tax)
$582,191.78/yr
After 10yr DRIP, annual income (after tax)
$1,106,694,573,767,997,900,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, PEAR beats the other by $1,106,694,573,767,997,900,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEAR + CL for your $10,000?

PEAR: 50%CL: 50%
100% CL50/50100% PEAR
Portfolio after 10yr
$669693703216606.88M
Annual income
$650,996,808,098,822,400,000.00/yr
Blended yield
97.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

PEAR
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Price Target
$6.50
+22160.3% upside vs current
Range: $5.00 — $8.00
Altman Z
-8.5
Piotroski
4/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEAR buys
0
CL buys
0
No recent congressional trades found for PEAR or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARCL
Forward yield6849.32%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$1339387406433213.75M$40.8K
Annual income after 10y$1,301,993,616,197,644,700,000.00$5,401.96
Total dividends collected$1336879923883212.75M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold
Analyst price target$6.50$92.45

Year-by-year: PEAR vs CL ($10,000, DRIP)

YearPEAR PortfolioPEAR Income/yrCL PortfolioCL Income/yrGap
1← crossover$695,632$684,931.51$11,012$312.01+$684.6KPEAR
2$45,273,292$44,528,966.00$12,196$412.95+$45.26MPEAR
3$2,756,897,651$2,708,455,228.62$13,599$549.66+$2756.88MPEAR
4$157,090,270,836$154,140,390,350.12$15,288$736.64+$157090.26MPEAR
5$8,376,539,704,888$8,208,453,115,093.00$17,353$995.28+$8376539.69MPEAR
6$418,028,448,270,623$409,065,550,786,392.40$19,926$1,357.80+$418028448.25MPEAR
7$19,526,057,962,883,308$19,078,767,523,233,740.00$23,194$1,873.82+$19526057962.86MPEAR
8$853,759,153,007,212,900$832,866,270,986,927,700.00$27,439$2,621.52+$853759153007.19MPEAR
9$34,947,467,509,877,550,000$34,033,945,216,159,830,000.00$33,088$3,727.38+$34947467509877.52MPEAR
10$1,339,387,406,433,213,700,000$1,301,993,616,197,644,700,000.00$40,806$5,401.96+$1339387406433213.75MPEAR

PEAR vs CL: Complete Analysis 2026

PEARStock

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Full PEAR Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this PEAR vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEAR vs SCHDPEAR vs JEPIPEAR vs OPEAR vs KOPEAR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.